Table of Contents AVNET, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) The following is a summary of the changes in outstanding options for fiscal 2019: (1) The above table excludes the Performance Based Stock Options (“PBSOs”). Since the performance metrics for the PBSOs were not achieved by the end of calendar year 2018, as stated in the PBSO Terms and Conditions, although the shares have not yet been canceled, the Company has excluded from the outstanding stock options above. The weighted-average grant-date fair values of stock options granted during fiscal 2019, 2018 and 2017 were $10.74, $8.33 and $9.46, respectively. At June 29, 2019, the aggregate intrinsic value of all outstanding stock option awards was $6.6 million and all exercisable stock option awards was $4.4 million.  The following is a summary of the changes in non-vested stock options for the fiscal year 2019: Weighted Weighted Average Average Remaining  Shares Exercise Price Contractual Life Outstanding at June 30, 2018 2,321,787 $ 40.93 79 Months Granted 301,148 48.50 110 Months Exercised (559,796) 36.14 49 Months Forfeited or expired  (826,500)  46.98 91 Months Outstanding at June 29, 2019  1,236,639 $ 40.90 78 Months Exercisable at June 29, 2019 545,166 $ 37.41 60 Months (1) (1) Weighted Average Grant-Date Shares Fair Value Non-vested stock options at June 30, 2018 1,455,234 $ 11.05 Granted 301,148 10.74 Vested (238,409) 10.23 Forfeited  (826,500)  12.05 Non-vested stock options at June 29, 2019 691,473 $ 10.00 (1) (1) Included in forfeitures above are the PBSOs, as noted above in the changes in outstanding stock options table As of June 29, 2019, there was $3.2 million of total unrecognized compensation cost related to stock options, which is expected to be recognized over a weighted-average period of 2.3 years. The total fair value of stock options vested, as of the vesting dates, during fiscal 2019, 2018 and 2017 were $5.7 million, $3.6 million and $3.3 million, respectively. Cash received from stock option exercises during fiscal 2019, 2018, and 2017 totaled $20.2 million, $9.2 million, and $25.2 million, respectively. The impact of these cash receipts is included in “Other, net” within financing activities in the accompanying consolidated statements of cash flows. 72